600285 羚銳製藥
按盤價 
25.670 -0.190 (-0.735%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.651 | 21.270 | 19.268 | 15.748 | 14.390 |
| 總資產報酬率 ROA (%) | 3.904 | 12.463 | 11.436 | 9.972 | 9.611 |
| 投入資產回報率 ROIC (%) | 6.164 | 19.204 | 17.403 | 14.643 | 13.178 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.597 | 73.293 | 72.280 | 74.272 | 76.908 |
| 營業利潤率 (%) | 24.292 | 19.819 | 17.227 | 16.150 | 15.744 |
| 息稅前利潤/營業總收入 (%) | 23.409 | 18.660 | 16.338 | 14.963 | 14.965 |
| 淨利潤/營業總收入 (%) | 20.937 | 17.156 | 15.501 | 13.458 | 13.913 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.254 | 96.191 | 80.738 | 96.014 | 91.646 |
| 價值變動淨收益/利潤總額(%) | 3.436 | 3.105 | 12.491 | 7.403 | 11.300 |
| 營業外收支淨額/利潤總額(%) | -0.003 | -0.500 | -0.017 | -5.240 | -0.794 | 償債能力分析 |
| 流動比率 (X) | 1.493 | 1.368 | 1.465 | 1.482 | 1.797 |
| 速動比率 (X) | 1.260 | 1.122 | 1.181 | 1.184 | 1.487 |
| 資產負債率 (%) | 40.948 | 41.351 | 41.114 | 39.724 | 32.842 |
| 帶息債務/全部投入資本 (%) | 3.158 | 7.043 | 7.415 | 6.539 | -- |
| 股東權益/帶息債務 (%) | 3,000.693 | 1,286.206 | 1,213.334 | 1,387.056 | 5,320.449 |
| 股東權益/負債合計 (%) | 143.836 | 141.446 | 142.802 | 151.232 | 203.656 |
| 利息保障倍數 (X) | -26.531 | -17.595 | -18.446 | -39.001 | -22.819 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 26.855 | 24.698 | 22.119 | 21.293 | 0.000 |
| 存貨周轉天數 (天) | 187.994 | 194.120 | 197.887 | 197.353 | 0.000 |
| 備註： | 即時報價更新時間為 15/05/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
